Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
Intevac, Inc. (NASDAQ:IVAC), ("Intevac" or the "Company), a leading supplier of thin-film processing systems, today announced the sale of its Photonics business ("Photonics") to EOTECH LLC, a
Intevac (NASDAQ:IVAC) reported its Q3 earnings results on Monday, November 1, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Intevac reported in-line EPS of $-0.16 versus an estimate of $-0.25, which surprised analysts.
Intevac (NASDAQ:IVAC) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.25) by 36 percent. This is a 1500 percent decrease over losses of $(0.01) per share from the same
Intevac (NASDAQ:IVAC) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement.
Analysts estimate that Intevac will likely report an Earnings Per Share (EPS) of $-0.25
Gainers
Intevac (NASDAQ:IVAC) stock moved upwards by 7.29% to $5.0 during Monday's after-market session. The market value of their outstanding shares is at $122.9 million.